The healthcare sector is grappling with an escalating threat from an insidious germ that's proving tough to combat. Infections induced by NDM-producing carbapenem-resistant Enterobacterales (CRE), bacteria notorious for their ability to resist even our most potent antibiotics, have skyrocketed recently. A recent, peer-reviewed examination reveals as astounding 460 percent hike in such cases from 2019…
